Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Exclusive - Germany may miss COVID-19 vaccine donation goal, blames manufacturers

Stock MarketsOct 20, 2021 03:26AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Cabins at a vaccination centre, temporarily set up in the Erika-Hess ice stadium to fight the coronavirus disease (COVID-19) pandemic are seen in Berlin, Germany, January 14, 2021. Kay Nietfeld/Pool via REUTERS

BERLIN (Reuters) - Germany may miss its target to donate 100 million COVID-19 vaccine doses this year due to conditions imposed by manufacturers and delivery shortfalls, a health ministry official said in a letter to Brussels seen by Reuters.

The 100 million doses account for half the total promised by European Union member states to poorer countries this year, according to the European Commission.

The German foreign office said on Oct. 19 that Germany had only donated just over 17% of that amount.

In a letter on Monday to the European Commission's Health Emergency Preparedness and Response Authority (HERA), health ministry state secretary Thomas Steffen said there were "ongoing bureaucratic, logistical and legal problems" imposed by vaccine makers on EU countries wanting to donate surplus shots.

Steffen said these factors made "a quick response to international requests for help almost impossible."

The letter is the strongest sign yet of the tensions between governments and drugmakers over donations.

The EU and rich countries, most of whose most vulnerable citizens have been vaccinated, are under pressure from the World Health Organization to deliver more doses to poorer nations, many of which have inoculated only a fraction of their people.

"With vaccine surpluses in many member states increasing at present, we will soon be facing a situation of global allocation emergency," Steffen wrote. "Some countries could be forced to waste large volumes of valuable vaccines urgently needed in other parts of the world."

He said obstacles included minimum sales prices, onerous compensation payments required of recipient countries and restrictions on distributing to international organisations.

Changes in expected delivery volumes and expiration dates of vaccine doses also made planning more difficult, he added.

Steffen said AstraZeneca (NASDAQ:AZN) and Johnson & Johnson (NYSE:JNJ) could together only deliver up to 50 million doses of their COVID-19 vaccines this year, meaning Germany would also have to donate Pfizer/BioNTech and Moderna (NASDAQ:MRNA) shots that are the mainstays of its vaccination drive.

In response, Johnson & Johnson said it would help countries with surplus doses to donate them to other countries, especially using the international COVAX facility, as long as the countries met safety, legal, regulatory and logistical requirements.

AstraZeneca said it was supporting donations in addition to regular supply agreements with individual countries and COVAX, and said it had helped with about 85% of all donations in Germany so far.

"The donation of vaccines is a complex administrative process with long lead times that are outside vaccine manufacturers' control," it added.

Other manufacturers could not immediately be reached for comment.

EU countries have mostly promised to donate AstraZeneca and Johnson & Johnson vaccines. Many have restricted the use of these vaccines due to very rare cases of blood clotting.

Any shortfall in donations is likely to heighten criticism of richer nations, which are rolling out boosters and inoculating teenagers considered a low-risk from COVID-19, while the pandemic rages elsewhere.

Exclusive - Germany may miss COVID-19 vaccine donation goal, blames manufacturers
 

Related Articles

AstraZeneca China summoned over suspected fraud
AstraZeneca China summoned over suspected fraud By Reuters - Jan 29, 2022

BEIJING (Reuters) -Chinese authorities summoned officials of AstraZeneca (NASDAQ:AZN) China regarding an investigation of suspected medical insurance fraud by the company's...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email